LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $282,000 | -17.8% | 2,151 | -4.4% | 0.00% | -50.0% |
| Q1 2021 | $343,000 | +55.2% | 2,251 | +13.7% | 0.00% | +100.0% |
| Q2 2020 | $221,000 | -47.8% | 1,980 | -51.2% | 0.00% | -50.0% |
| Q4 2019 | $423,000 | -59.8% | 4,060 | -61.6% | 0.00% | -66.7% |
| Q3 2019 | $1,053,000 | -5.8% | 10,580 | +8.1% | 0.01% | 0.0% |
| Q2 2019 | $1,118,000 | -34.3% | 9,790 | -27.7% | 0.01% | -33.3% |
| Q1 2019 | $1,702,000 | +68.8% | 13,540 | +82.4% | 0.01% | +50.0% |
| Q4 2018 | $1,008,000 | -23.7% | 7,425 | +54.3% | 0.01% | -14.3% |
| Q3 2018 | $1,321,000 | +119.8% | 4,811 | +65.8% | 0.01% | +133.3% |
| Q2 2018 | $601,000 | +25.5% | 2,901 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $479,000 | +21.6% | 2,901 | +0.7% | 0.00% | +50.0% |
| Q4 2017 | $394,000 | +71.3% | 2,881 | +70.3% | 0.00% | +100.0% |
| Q3 2017 | $230,000 | +11.1% | 1,692 | -12.3% | 0.00% | -50.0% |
| Q1 2016 | $207,000 | – | 1,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |